Results 241 to 250 of about 47,533 (300)

APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer [PDF]

Yulin Liu, Zhuo Xiang, Boya Zhang, Yuwei Zou, Gui-lai Chen, Li Yin, Yanlong Shi, Li-Li Xu, Jingwang Bi, Qiang Wang   +9 more
openalex   +1 more source

NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer. [PDF]

World J Gastroenterol
Niu YR, Xiang MD, Yang WW, Fang YT, Qian HL, Sun YK.   +5 more
europepmc   +1 more source

A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer using Oxaliplatin and Coxsackievirus A11

A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer using Oxaliplatin and Coxsackievirus A11
Background: Colorectal cancer (CRC) is a major cause of morbidity and mortality throughout the world. It is the third most common cancer worldwide and the fourth most common cause of cancer-related death. FOLFOX, a combination of leucovorin calcium, fluorouracil, and oxaliplatin, is the first-line chemotherapy for stage III and stage IV CRC.
openaire  

Research Progress on Reversing Oxaliplatin Resistance in Colon Cancer

Advances in Clinical Medicine, 2023
openaire   +1 more source

Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription

Sainan Li, Shan Yang, Hao‐Qi Wang, Tianli Hui, Meng Cheng, Xi Zhang, Bao-Kun Li, Guiying Wang   +7 more
openalex   +1 more source

RETRACTION: LncRNA NR2F1-AS1 Regulates Hepatocellular Carcinoma Oxaliplatin Resistance by Targeting ABCC1 via miR-363. [PDF]

J Cell Mol Med
europepmc   +1 more source

Oxaliplatin Activated LINC00205/miR-495-3p/CMTM6 Through Inducing H3K4me1 to Promote Oxaliplatin Resistance of Gastric Cancer

Lijing Zhou, Heyu Zhang, Lei Zhang, Ganghua Yang, Qinhong Xu, Yan Guo   +5 more
openalex   +1 more source

Increased keratin 80 expression predicts poor prognosis and promotes oxaliplatin resistance in gastric cancer. [PDF]

World J Gastroenterol
Yang B, Cao HX, He YW, Ouyang JJ, Lv M, Li YX, Lu YD.   +6 more
europepmc   +1 more source

<p>SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway</p>

, 2019
Hailiang Ren, Zheng Wang, Yao Chen, Yanjun Liu, Shu Zhang, Tongtong Zhang, Yuntao Li   +6 more
openalex   +2 more sources

[Tumor-secreted dentin sialophosphoprotein induces oxaliplatin resistance in colorectal cancer through an integrin αvβ3-dependent pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liu C, Ning Z, Wu J, Liu W, Lin C, Xu J, Zhou R, Zhao L.   +7 more
europepmc   +1 more source